Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.
Gundolf SchuettfortL BoekenkampAlfonso Cabello ÚbedaA G CotterP De LeuwJ DoctorM GórgolasL HamzahE HerrmannG KannP KhaykinP W MallonAlvaro MenaM Del Palacio TamaritCaroline Anne SabinC StephanTimo WolfA E HaberlPublished in: HIV medicine (2020)
In a European cohort of late presenters starting first-line INI or PI-based ART regimens, there were no significant differences in discontinuation proportions or virological response at week 48.